Publications scientifiques sur la correction de l’autisme par des cellules souches autologues

1. Dawson G, Sun JM, Davlantis KS, Murias M, Franz L, Troy J, Simmons R, Sabatos-DeVito M, Durham R, Kurtzberg J. Stem Cells Transl Med. 2017 May;6(5):1332-1339. Autologous Cord Blood Infusions Are Safe and Feasible in Young Children with Autism Spectrum Disorder: Results of a Single-Center Phase I Open-Label Trial.

2. Dario Siniscalco, James Jeffrey Bradstreet, and Nicola Antonucci. Therapeutic Role of Hematopoietic Stem Cells in Autism Spectrum Disorder-Related Inflammation. Front Immunol. 2013; 4:140.

3. https://clinicaltrials.gov/ct2/show/NCT01638819

4. https://clinicaltrials.gov/ct2/show/NCT02176317

5. https://clinicaltrials.gov/ct2/show/NCT02847182

6. https://clinicaltrials.gov/ct2/show/NCT01343511

7. Lv YT, Zhang Y, Liu M, Qiuwaxi JN, Ashwood P, Cho SC, Huan Y, Ge RC, Chen XW, Wang ZJ, Kim BJ, Hu X. Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. J Transl Med. 2013. 11:196.

8. Michael Chez, Christopher Lepage, Carol Parise, Ashley Dang‐Chu, Andrea Hankins, and Michael Carroll. Safety and Observations from a Placebo‐Controlled, Crossover Study to Assess Use of Autologous Umbilical Cord Blood Stem Cells to Improve Symptoms in Children with Autism. STEM CELLS TRANSLATIONAL MEDICINE 2018;7:333–341

9. Sharma A, Gokulchandran N, Sane H, Nagrajan A, Paranjape A, Kulkarni P, Shetty A, Mishra P, Kali M, Biju H, Badhe P. Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study. Stem Cells Int. 2013;2013:623875. doi: 10.1155/2013/623875.